Kyntra Bio, Inc.
KYNB· Nasdaq
KYNBKyntra Bio, Inc.
Source filing unavailable
| Metric | Q2 2015 | Q2 2014 |
|---|---|---|
| Revenue | $120.55M | $89.96M |
| Net Income | $57.06M | $46.83M |
| EPS Diluted | $0.83 | $0.58 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
